Here are 3 things you should know about the multimodal treatment of patients with SCLC.
Lauren Averett Byers, MD
Advertisement
Articles by Lauren Averett Byers, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Trastuzumab Deruxtecan Regimen Accepted for Review in HER2+ Breast Cancer
3
FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer
4
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
5
